Abbott Laboratories (ABT)
(Real Time Quote from BATS)
$105.69 USD
-3.52 (-3.22%)
Updated Apr 17, 2024 02:44 PM ET
2-Buy of 5 2
C Value D Growth F Momentum D VGM
Price, Consensus and EPS Surprise
ABT 105.69 -3.52(-3.22%)
Will ABT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ABT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ABT
Q1 Earnings Review
Markets Try to Shake Off April Blues
ABT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
Abbott (ABT) Reports Q1 Earnings: What Key Metrics Have to Say
Abbott (ABT) Tops Q1 Earnings and Revenue Estimates
Other News for ABT
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
See Which Of The Latest 13F Filers Holds Abbott Laboratories
What You Missed On Wall Street This Morning
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024
Relative Strength Alert For Abbott Laboratories